ROMAN: Phase 3 trial of avasopasem manganese (GC4419) for severe oral mucositis (SOM) in patients receiving chemoradiotherapy (CRT) for locally advanced, nonmetastatic head and neck cancer (LAHNC).-MedSci.cn

ROMAN: Phase 3 trial of avasopasem manganese (GC4419) for severe oral mucositis (SOM) in patients receiving chemoradiotherapy (CRT) for locally advanced, nonmetastatic head and neck cancer (LAHNC).

Anderson, CM; Lee, CM; Kelley, JR; Walker, GV; Dunlap, NE; Bar-Ad, VC; Miller, DA; King, VJ; Peddada, AV; Ciuba, DF; Vincent, F; Muzyka, BC; Gillespie-Twardy, AL; Sonis, ST; Holmlund, J; Saunders, D

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):

科室
- - 订阅+
  - 更多科室
工具
服务